Sign in
CompletedPhase 1/2

Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

Key facts

Who runs it
CHA University
Where
South Korea2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1/2
People taking part
102 people enrolled
Started
1 Mar 2022
Ended
28 Feb 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Dexamethasone
Record updated
15 June 2026

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Sepsis defined by Sepsis-3 definition
  • Initial systolic blood pressure < 90mmHg or blood lactate level >2mmol/L

Who cannot take part

  • recent systemic administration of chemotherapy (4 weeks)
  • advanced directive for "Do not resuscitation"
  • recent systemic administration of glucocorticoid (4 weeks)
  • recent systemic administration of immunosuppressant (4 weeks)
  • expected life less than 90 days
  • Transferred from other hospital
  • Sepsis diagnosed 24 hours after ED admission
  • Use of etomidate in ED
  • pregnant or on lactation
  • no informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.

The 3 groups in the trial

  • PlaceboNo study treatment, for comparison

    normal saline

  • low dose dexamethasoneTreatment being tested

    0.1 mg/kg dexamethasone iv once per day, for 1 or 2 days

    Treatment: Dexamethasone

  • high dose dexamethasoneTreatment being tested

    0.2 mg/kg dexamethasone iv once per day, for 1 or 2 days

    Treatment: Dexamethasone

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Double-blind, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
Publications
Record updated
15 June 2026